HomeActualitésActualités des entreprises

Hybio Pharmaceutical Co.Ltd(300199) réponse à la lettre d

avril 13, 2022

Le 13 avril, Hybio Pharmaceutical Co.Ltd(300199) Sur la base des progrès de la recherche et du développement susmentionnés, la compagnie estime que la description du covid – 19 par pulvérisation nasale est exacte.

- Advertisment -

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Toujours activé

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Durée	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Hybio Pharmaceutical Co.Ltd(300199) réponse à la lettre d

Tolérance zéro ! Une action réglementaire lourde ! Ces deux entreprises pourraient être ra...

La foudre ! Le bénéficiaire effectif de la société a disparu ! Eventuellement impliqué dan...

Le président du conseil d’administration de “Tooth Maw” a été déposé par...

Kalite : Annonce de l’introduction en bourse des actions et de l’inscription s...

Matrix : Avis juridique de Guoco Law Firm (Shenzhen) sur l’offre publique initiale d...

Weigang Technology : Prospectus d’introduction en bourse

Weigang Technology : Annonce de l’offre publique initiale d’actions

Weigang Technology : Résumé du prospectus d’introduction en bourse

Weigang Technology : Annonce spéciale sur les risques d’investissement de l’of...

601136:Première offre publique d’actions par Capital Securities Première annonce spé...

601136:Annonce du résultat de la cotation préliminaire et report de l’offre publique...